More Ammo Against Withdrawn Surgery Drug

(AP) -- Heart surgery patients were more likely to die if given the anti-bleeding drug Trasylol, two more U.S. studies have found, renewing the claims that the drug is dangerous. Bayer AG stopped selling the drug last fall, after a Canadian study was halted because of deaths among patients taking Trasylol.